Evaluation of the efficacy of an antioxidant combination for the modulation of metabolic, endocrine, and clinical parameters in patients with polycystic ovary syndrome

References

• Teede HJ, Misso ML, Costello MF, et al. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Clin Endocrinol (Oxf). 2018;89(3):1–6. doi: 10.1111/cen.13795.
   Web of Science ®Google Scholar
• Skiba MA, Islam RM, Bell RJ, et al. Understanding variation in prevalence estimates of polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2018;24(6):694–709. doi: 10.1093/humupd/dmy022.
   PubMed Web of Science ®Google Scholar
• Calcaterra V, Verduci E, Cena H, et al. Polycystic ovary syndrome in insulin-resistant adolescents with obesity: the role of nutrition therapy and food supplements as a strategy to protect fertility. Nutrients. 2021;13(6):1848. doi: 10.3390/nu13061848.
   PubMed Web of Science ®Google Scholar
• Oguz SH, Yildiz BO. An update on contraception in polycystic ovary syndrome. Endocrinol Metab (Seoul). 2021;36(2):296–311. doi: 10.3803/EnM.2021.958.
   PubMedGoogle Scholar
• Naderpoor N, Shorakae S, de Courten B, et al. Metformin and lifestyle modification in polycystic ovary syndrome: systematic review and meta-analysis. Hum Reprod Update. 2015;21(5):560–574. doi: 10.1093/humupd/dmv025.
   PubMed Web of Science ®Google Scholar
• Fraison E, Kostova E, Moran LJ, et al. Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome. Cochrane Database Syst Rev. 2020;8(8):CD005552.
   PubMedGoogle Scholar
• Di Tucci C, Di Feliciantonio M, Vena F, et al. Alpha lipoic acid in obstetrics and gynecology. Gynecol Endocrinol. 2018;34(9):729–733. doi: 10.1080/09513590.2018.1462320.
   PubMed Web of Science ®Google Scholar
• Genazzani AD, Shefer K, Della Casa D, et al. Modulatory effects of alpha-lipoic acid (ALA) administration on insulin sensitivity in obese PCOS patients. J Endocrinol Invest. 2018;41(5):583–590. doi: 10.1007/s40618-017-0782-z.
   PubMed Web of Science ®Google Scholar
• Cheraghi E, Soleimani Mehranjani M, Shariatzadeh SMA, et al. N-acetylcysteine compared to metformin, improves the expression profile of growth differentiation factor-9 and receptor tyrosine kinase c-Kit in the oocytes of patients with polycystic ovarian syndrome. Int J Fertil Steril. 2018;11(4):270–278.
   PubMed Web of Science ®Google Scholar
• Fulghesu AM, Ciampelli M, Muzj G, et al. N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome. Fertil Steril. 2002;77(6):1128–1135. doi: 10.1016/s0015-0282(02)03133-3.
   PubMed Web of Science ®Google Scholar
• Günalan E, Yaba A, Yilmaz B. The effect of nutrient supplementation in the management of polycystic ovary syndrome-associated metabolic dysfunctions: a critical review. J Turk Ger Gynecol Assoc. 2018;19(4):220–232.
   PubMed Web of Science ®Google Scholar
• Mato JM, Alonso C, Noureddin M, et al. Biomarkers and subtypes of deranged lipid metabolism in non-alcoholic fatty liver disease. World J Gastroenterol. 2019;25(24):3009–3020. doi: 10.3748/wjg.v25.i24.3009.
   PubMed Web of Science ®Google Scholar
• Cronin L, Guyatt G, Griffith L, et al. Development of a health-related quality-of-life questionnaire (PCOSQ) for women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab. 1998;83(6):1976–1987. doi: 10.1210/jc.83.6.1976.
   PubMed Web of Science ®Google Scholar
• Shashaj B, Luciano R, Contoli B, et al. Reference ranges of HOMA-IR in normal-weight and obese young caucasians. Acta Diabetol. 2016;53(2):251–260. doi: 10.1007/s00592-015-0782-4.
   PubMed Web of Science ®Google Scholar
• Song Y, Wang H, Huang H, et al. Comparison of the efficacy between NAC and metformin in treating PCOS patients: a meta-analysis. Gynecol Endocrinol. 2020;36(3):204–210. doi: 10.1080/09513590.2019.1689553.
   PubMed Web of Science ®Google Scholar
• Chełchowska M, Jurczewska J, Gajewska J, et al. Antioxidant defense expressed as glutathione status and Keap1-Nrf2 system action in relation to anthropometric parameters and body composition in young women with polycystic ovary syndrome. Antioxidants (Basel). 2023;12(3):730. doi: 10.3390/antiox12030730.
   PubMedGoogle Scholar
• Murri M, Luque-Ramírez M, Insenser M, et al. Circulating markers of oxidative stress and polycystic ovary syndrome (PCOS): a systematic review and meta-analysis. Hum Reprod Update. 2013;19(3):268–288. doi: 10.1093/humupd/dms059.
   PubMed Web of Science ®Google Scholar
• Guarino MP, Macedo MP. Co-administration of glutathione and nitric oxide enhances insulin sensitivity in Wistar rats. Br J Pharmacol. 2006;147(8):959–965. doi: 10.1038/sj.bjp.0706691.
   PubMed Web of Science ®Google Scholar
• Zhang J, An H, Ni K, et al. Glutathione prevents chronic oscillating glucose intake-induced beta-cell dedifferentiation and failure. Cell Death Dis. 2019;10(4):321. doi: 10.1038/s41419-019-1552-y.
   PubMedGoogle Scholar
• Desmawati, Febri RR, Hestiantoro A, et al. DNA methylation of the androgen receptor gene promoter in the granulosa cells of polycystic ovary syndrome patients. J Phys: Conf Ser. 2018;1073:032078. doi: 10.1088/1742-6596/1073/3/032078.
   Google Scholar
• Pan JX, Tan YJ, Wang FF, et al. Aberrant expression and DNA methylation of lipid metabolism genes in PCOS: a new insight into its pathogenesis. Clin Epigenetics. 2018;10:6. doi: 10.1186/s13148-018-0442-y.
   PubMed Web of Science ®Google Scholar
• Moore LD, Le T, Fan G. DNA methylation and its basic function. Neuropsychopharmacology. 2013;38(1):23–38. doi: 10.1038/npp.2012.112.
   PubMed Web of Science ®Google Scholar
• Garicano VE, Sanz RS, López Oliva S, et al. editors. Effect of MetioNac® in patients with nonalcoholic fatty liver disease and risk of progression to nonalcoholic steatohepatitis: a pilot randomized controlled trial. XV International Congress of the Spanish Society of Dietetics and Food Science (SEDCA); 2022, March 29-30; Madrid, Spain.
   Google Scholar